A Seattle-area startup called Pauling.AI is harnessing artificial intelligence to automate the early steps that lead to the ...

After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical ...

Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to ...

SAN DIEGO--(BUSINESS WIRE)--Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, published on major advances ...

Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a ...

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

AI in drug discovery is evolving fast. Join the experts behind today’s real progress as they share what works, what doesn’t ...

Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...

Medra, which programs robots with artificial intelligence to conduct and improve biological experiments, has raised $52 ...

Chai Discovery, an artificial intelligence drug-discovery company backed by Sam Altman’s OpenAI, has secured $130 million ...

The local pharmacy used to be the default place to fill prescriptions, but like just about everything else, technology is ...